US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...
来自MSN1 天
'Big 3' pharmacy benefit managers marked up drugs by $7.3B: FTC
The three biggest pharmacy benefit managers marked up "lifesaving" medications to generate $7.3 billion in five years, ...
Honolulu Star-Advertiser15 小时
FTC: Pharmacy benefit managers inflated drug prices by $7.3B
WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...
FTC report shows $7.3 billion in drug price inflation by leading pharmacy benefit managers
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
BioSpace20 小时
Pharmacy Benefits Managers Netted Extra $7.3B by Inflating Drug Prices: FTC
A report published Tuesday shows hundreds and thousands of percent markups on HIV, hypertension and cancer drugs for Medicare ...
Healthcare Dive1 天
FTC releases second report slamming pharmacy benefit managers
Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...
Largest Pharmacy-Benefit Managers Hiked Up Drug Prices, FTC Says
The markups helped the pharmacy-benefit managers reap $7.3 billion from 2017 to 2022, the FTC found.
Pharmacy benefit managers have become too powerful
Pharmacy benefit managers make decisions about medication access that aren’t always based on the best interests of patients.
ConsumerAffairs22 小时
Another FTC report is highly critical of pharmacy benefit managers
In the debate over the high cost of prescription drugs, pharmacy benefit managers are hotly contested. PBMs, the middlemen in ...
Largest pharmacy-benefit managers hike up U.S. drug prices: FTC
The largest pharmacy-benefit managers PBMs hiked the prices of certain drugs dispensed through their own pharmacies according to a new report by th ...
KITV15 小时
Pharmacy benefit managers marked up drug prices by $7.3B, new reports finds
A new FTC report blames Pharmacy Benefit Managers for marking up specialty drug prices, profiting $7.3 billion from cancer and HIV treatments between 2017-2022.
Benefits Pro6 天
Illinois lawmaker seeks more oversight of pharmacy benefit managers, with new bill
The bill is similar to Pennsylvania's new law and would curb PBMs by setting rules for rebates, audits and specialty drug ...